On March 24, 2026, PTC Therapeutics, Inc. appointed Jessica Chutter to its board of directors, bringing over 40 years of healthcare investment banking experience. She will receive a base annual retainer of $50,000 and stock options totaling 3,475 shares and 4,000 restricted stock units, vesting over the next three years.